Synthesis and Biological Activity of Fluorinated Nucleosides

Fluorine in Medicinal Chemistry and Chemical Biology

Volumn , Issue , 2009, Pages 165-198

  Maruyama, Tokumi ^a   Ikejiri, Masahiro ^a   Izawa, Kunisuke ^b   Onishi, Tomoyuki ^b  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

Antiviral fluorinated nucleoside analogues; Biological activity of fluorinated nucleosides and correlations with conformations; Fluorination with perfluoroalkanesulfonyl fluorides; Industrial synthesis of Fdd A; Introduction of fluorine atom(s) into drug candidate compounds; Syntheses and antiviral activities of FddA and FddG; Synthesis and biological activity of fluorinated nucleosides; Synthesis of nucleoside analogues bearing fluorine atom(s) in their sugar moieties

Indexed keywords

EID: 84889375451     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444312096.ch7     Document Type: Chapter

References (113)

1. Morton, G. O., Lancaster, J. E., Van Lear, G. E., et al. (1969) Structure of nucleocidin. III. Revised structure. J. Am. Chem. Soc., 91, 1535-1537.
2. Heidelberger, C., Chaudhuri, N. K., Danneberg, P., et al. (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compound. Nature, 179(4561), 663-666.
3. Hertel, L. W., Kroin, J. S., Misner, J. W. and Tustin, J. M. (1988) Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides. J. Org. Chem., 53, 2406-2409.
4. Bonate, P. L., Arthaud, L., Cantrell, W. R., Jr., et al. (2006) Discovery and development of clofarabine: a nucleoside analogue for treating cancer. Nat. Rev. Drug Discov., 5, 855-863.
5. Korba, B. E., Furman, P. A. and Otto, M. J. (2006) Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo. Expert Rev. Anti-Infect. Ther., 4, 549-561.
6. Billich, A. (1999) Lodenosine. Curr. Opin. Anti-Infect. Invest. Drugs, 1, 179-185.
7. De Clercq, E. (2005) Emerging anti-HIV drugs. Expert Opin. Emerg. Drugs, 10, 241-274.
8. Rusconi, S. (2003) Alovudine (Medivir). Curr. Opin. Investig. Drugs (Thomson Current Drugs) 4, 219-223.
9. Takamatsu, S., Maruyama, T. and Izawa, K. (2005) Development of an industrial process for synthesizing lodenosine (FddA). Yuki Gosei Kagaku Kyokaishi, 63, 864-878.
10. Izawa, K., Takamatsu, S., Katayama, S., et al. (2003) An industrial process for synthesizing lodenosine (FddA). Nucleosides, Nucleotides Nucleic Acids, 22, 507-517.
11. Izawa, K., Torii, T., Onishi, T. and Maruyama, T. (2007) The synthesis of an antiviral fluorinated purine nucleoside: 3' -a-fluoro-2',3'-dideoxyguanosine. Current Fluoroorganic Chemistry, ACS Symposium Series 949, pp. 363-378.
12. Herdewijn, P., Van Aerschot, A. and Kerremans, L. (1989) Synthesis of nucleosides fluorinated in the sugar moiety. The application of diethylaminosulfur trifluoride to the synthesis of fluorinated nucleosides. Nucleosides Nucleotides, 8, 65-96.
13. Pankeiwicz, K. W. (2000) Fluorinated nucleosides. Carbohydr. Res., 327, 87-105.
14. Pankeiwicz, K. W. and Watanabe, K. A. (1993) Synthesis of 2'-ß-fluoro-substituted nucleosides by a direct approach. J. Fluorine Chem., 64, 15-36.
15. Saenger, W. (1984) Pronciples of Nucleic Acid Structure. Springer-Verlag, New York.
16. Codington, J. F., Doerr, I. L. and Fox, J. J. (1964) Nucleoside. XVIII. Synthesis of 2'-fluorothymidine, 2'-fluorodeoxyuridine, and other 2'-halogeno-2'-deoxy nucleosides. J. Org. Chem., 29, 558-564.
17. Kowollik, G., Gaertner, K. and Langen, P. (1975) Nucleosides of fluorocarbohydrates. XIII. Synthesis of 3'-deoxy-3'-fluorouridine. J. Carbohydr., Nucleosides, Nucleotides, 2, 191-195.
18. Misra, H. K., Gati, W. P., Knaus, E. E. and Wiebe, L. I. (1984) Reaction of 1-(2',3'-epoxy-ß-D-lyxofuranosyl)uracil with hydrogen fluoride. The unexpected formation of 1-(3'-fluoro-3'-deoxy-ß-D-ribofuranosyl)uracil. J. Heterocyclic Chem., 21, 773-775.
19. Ikehara, M. and Maruyama, T. (1976) Studies of nucleosides and nucleotides. LXIX. Purine cyclonucleosides. (30). Elimination of the 8-oxy function of purine nucleosides. Chem. Pharm. Bull., 24, 565-569.
20. Ikehara, M., Maruyama, T., Miki, H. and Takatsuka, Y. (1977) Studies of nucleosides and nucleotides. LXXXV. Purine cyclonucleosides. (35). Synthesis of purine nucleosides having 2'-azido and 2'-amino functions by cleavage of purine cyclonucleosides. Chem. Pharm. Bull., 25, 754-760.
21. Wagner, J., Verheyden, J. P. H. and Moffatt, J. G. (1974) Preparation and synthetic utility of some organotin derivatives of nucleosides. J. Org. Chem., 39, 24-30.
22. Ikehara, M. and Maruyama, T. (1975) Studies of nucleosides and nucleotides-LXV: Purine cyclonucleosides-26 a versatile method for the synthesis of purine O- cyclo-nucleosides. The first synthesis of 8,2'-anhydro-8-oxy 9-ß-D-arabinofuranosylguanine. Tetrahedron, 31, 1369-1372.
23. Ikehara, M., Maruyama, T. and Miki, H. (1976) A new method for the synthesis of 2'-substi-tuted purine nucleosides. Total synthesis of an antibiotic 2' -amino-2'-deoxyguanosine. Tetrahedron Lett., 17, 4485-1488.
24. Ikehara, M. and Miki, H. (1978) Studies of Nucleosides and Nucleotides. LXXXII. Cyclonu-cleosides. (39). Synthesis and Properties of 2'-Halogeno-2'-deoxyadenosines. Chem. Pharm. Bull., 26, 2449-2453.
25. Ikehara, M. and Imura, J. (1981) Studies on nucleosides and nucleotides. LXXXVII. Purine cyclonucleosides. XLII. Synthesis of 2'-deoxy-2'-fluoroguanosine. Chem. Pharm. Bull., 29, 1034-1038.
26. Ranganathan, R. (1977) Modification of the 2'-position of purine nucleosides: syntheses of 2'-a-substituted-2'-deoxyadenosine analogs. Tetrahedron Lett., 18, 1291-1294.
27. McOmie, J. F. W. (1973) Protective Groups in Organic Chemistry. Plenum Press, New York.
28. Nishino, S., Takamura, H. and Ishido, Y. (1986) Regioselective protection of carbohydrate derivatives. Part 20. Simple, efficient 2'-O-deacylation of fully acylated purine and pyrimidine ribonucleosides through tert-butoxide. Tetrahedron, 42, 1995-2004.
29. Markiewicz, W. T. and Wiewiorowski, M. (1978) A new type of silyl protecting groups in nucleoside chemistry. Nucleic Acids Res., Spec. Publ., 4, 185-188.
30. Markiewicz, W. T. (1975) Tetraisopropyldisiloxane-1,3-diyl, a group for simultaneous protection of 3-and 5 -hydroxy functions of nucleosides. J. Chem. Res., Synopses, 24-25.
31. Maruyama, T., Utzumi, K., Sato, Y. and Richman, D. D. (1994) Synthesis and anti-HIV activity of 6-substituted purine 2'-deoxy-2'-fluororibosides. Nucleosides Nucleotides, 13, 527-537.
32. Maruyama, T., Utzumi, K., Sato, Y. and Richman, D. D. (1994) Synthesis and anti-HIV activity of 2-substituted 2'-deoxy-2'-fluoroadenosines. Nucleosides Nucleotides, 13, 1219-1230.
33. Suhadolnik, R. J. (1979) Nucleosides as Biological Probes. John Wiley and Sons, Inc., New York, pp. 96-102.
34. Maruyama, T., Utsumi, K., Tomioka, H., et al. (1995) Synthesis, antiviral, antibacterial and antitumor cell activities of 2'-deoxy-2'-fluoropuromycin. Chem. Pharm. Bull., 43, 955-959.
35. Koizumi, F., Oritani, T. and Yamashita, K. (1990) Synthesis and antimicrobial activity of 2 -deoxypuromycin. Agric. Biol. Chem., 54, 3093-3097.
36. Ledoux, L. and Baltus, E. (1954) The effect of ribonuclease on the cells of the Ehrlich carcinoma. Experientia, 10, 500-501.
37. Youle, R. J. and D'Alessio, G. (1997) Ribonucleases: Structures and Functions. Academic Press, New York, pp. 491-514.
38. Nonaka, T., Nakamura, K. T., Uesugi, S., et al. (1993) Crystal structure of ribonuclease Ms (as a ribonuclease T1 homolog) complexed with a guanylyl- 3,5-cytidine analog. Biochemistry, 32, 11825-11837.
39. Ikehara, M. and Imura, J. (1981) Studies on nucleosides and nucleotides. LXXXIX. Purine cyclonucleosides. (43). Synthesis and properties of 2-halogeno-2-deoxyguanosines. Chem. Pharm. Bull., 29, 3281-3285.
40. Benseler, F., Williams, D. M. and Eckstein, F. (1992) Synthesis of suitably-protected phosphoramidites of 2'-fluoro-2'-deoxyguanosine and 2'-amino-2'-deoxyguanosine for incorporation into oligoribonucleotides. Nucleosides, Nucleotides, Nucleic Acids, 11, 1333-1351.
41. Maruyama, T., Kozai, S., Nakamura, K. and Irie, M. (2002) Synthesis of 2'-deoxy-2'-fluoroguanyl-(3',5')-guanosine. Nucleosides, Nucleotides, Nucleic Acids, 21, 765-774.
42. Honda, K., Komoda, Y., Nishida, S., et al. (1984) Uridine as an active component of sleep-promoting substance: its effects on nocturnal sleep in rats. Neurosci. Res., 1, 243-252.
43. Yamamoto, I., Kimura, T., Takeoka, Y., et al. (1987) N-Substituted oxopyrimidines and nucleo-sides: structure-activity relationship for hypnotic activity as CNS depressant. J. Med. Chem., 30, 2227-2231.
44. Sato, Y., Utsumi, K., Maruyama, T., et al. (1994) Synthesis and hypnotic and anti-human immunodeficiency virus-1 activities of N3-Substituted 2'-Deoxy-2'-fluorouridines. Chem. Pharm. Bull., 42, 595-598.
45. Pankiewicz, K. W. and Watanabe, K. A. (1987) Nucleosides. CXLIII. Synthesis of 5'-deoxy-5-substituted-2,2-anhydro-1-(ß -D- arabinofuranosyl)uracils. A new 2,5-to 2,2-anhydronucle-oside transformation. Studies directed toward the synthesis of 2-deoxy-2-substituted arabino nucleosides. (4). Chem. Pharm. Bull., 35, 4494-4497.
46. Matsuda, A., Yasuoka, J. and Ueda, T. (1989) Anew method for synthesizing the antineoplastic nucleosides 1- (2-azido-2-deoxy -ß -D- arabinofuranosyl)cytosine (Cytarazid) and 1- (2-amino-2 -deoxy -ß -D- arabinofuranosyl)cytosine (Cytaramin) from uridine. Chem. Pharm. Bull., 37, 1659-1661.
47. Pankiewicz, K. W., Krzeminski, J., Ciszewski, L. A., et al. (1992) A synthesis of 9-(2-deoxy-2-fluoro-ß -D-arabinofuranosyl)adenine and -hypoxanthine. An effect of C3'-endo to C2'-endo conformational shift on the reaction course of 2' -hydroxyl group with DAST. J. Org. Chem., 57, 553-559.
48. Krzeminski, J., Nawrot, B., Pankiewicz, K. W. and Watanabe, K. A. (1991) Synthesis of 9-(2-deoxy-2-fluoro-ß-D-arabinofuranosyl)hypoxanthine. The first direct introduction of a 2'-ß-fluoro substituent in preformed purine nucleosides. Studies directed toward the synthesis of 2' -deoxy-2'-substituted arabinonucleosides. 8. Nucleosides Nucleotides, 10, 781-798.
49. Maruyama, T., Sato, Y., Oto, Y., et al. (1996) Synthesis and antiviral activity of 6-chloropurine arabinoside and its 2' -deoxy-2'-fluoro derivative. Chem. Pharm. Bull., 44, 2331-2334.
50. Uesugi, S., Miki, H., Ikehara, M., et al. (1979) A linear relationship between electronegativity of 2 -substituents and conformation of adenine nucleosides. Tetrahedron Lett., 20, 4073-4076.
51. Maruyama, T., Takamatsu, S., Kozai, S., et al. (1999) Synthesis of 9-(2-deoxy-2-fluoro-ß-D-arabinofuranosyl)adenine bearing a selectively removable protecting group. Chem. Pharm. Bull., 47, 966-970.
52. Siddiqui, M. A., Driscoll, J. S. and Marquez, V. E. (1998) A new synthetic approach to the clinically useful, anti-HIV-active nucleoside, 9-(2,3-dideoxy-2-fluoro-ß-D-threo-pentofuranosyl)adenine (ß-FddA). Introduction of a 2'-ß-fluoro substituent via inversion of a readily obtainable 2'-a-fluoro isomer. Tetrahedron Lett., 39, 1657-1660.
53. Marquez, V. E., Tseng, C. K.-H., Kelley, J. A., et al. (1987) 2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). Biochem. Pharmacol., 36, 2719-2722.
54. Marquez, V. E., Tseng, C. K.-H., Mitsuya, H., et al. (1990) Acid-stable 2'-fluoro purine dide-oxynucleosides as active agents against HIV. J. Med. Chem., 33, 978-985.
55. Ruxrungtham, K., Boone, E. B., Ford, H., Jr., et al. (1996) Potent activity of 2'-ß-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice. Antimicrob. Agents Chemother., 40, 2369-2374.
56. Graul, A., Silvestre, J. and Castaner, J. (1998) Lodenosine: anti-HIV (reverse transcriptase inhibitor). Drugs Future, 23, 1176-1189.
57. Driscoll, J. S., Mayers, D. L., Bader, J. P., et al. (1997) 2'-Fluoro-2',3'-dideoxyarabinosylade-nine (F-ddA): activity against drug-resistant human immunodeficiency virus strains and clades A-E. Antivir. Chem. Chemother., 8, 107-111.
58. Tanaka, M, Srinivas, R. V., Ueno, T., et al. (1997) In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-ß-fluoro-2',3'-dideoxyadenosine. Antimicrob. Agents Chemother., 41, 1313-1318.
59. Singhal, D., Morgan, M. E. and Anderson, B. D. (1997) Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2 -ß -fluoro-2',3'-dideoxyinosine and 2'-ß-fluoro-2',3'-dideoxy-adenosine in rats. Pharmaceutical Res., 14, 786-792.
60. Driscoll, J. S., Siddiqui, M. A., Ford, H., Jr., et al. (1996) Lipophilic, acid-stable, adenosine deaminase-activated anti-hiv prodrugs for central nervous system delivery. 3. 6-Amino pro-drugs of 2'-ß-fluoro-2',3'-dideoxyinosine. J. Med. Chem., 39, 1619-1625.
61. Johnson, M. D. and Anderson, B. D. (1996) Localization of purine metabolizing enzymes in bovine brain microvessel endothelial cells: an enzymic blood-brain barrier for dideoxynucleo-sides? Pharm. Res., 13, 1881-1886.
62. Ford, H., Jr., Siddiqui, M., Driscoll, J. S., et al. (1995) Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo-and 6 -alkoxy prodrugs of 2'-ß-fluoro-2',3'-dideoxyinosine. J. Med. Chem., 38, 1189-1195.
63. Johnson, M. D., Chen, J. and Anderson, B. D. (2002) Investigation of the mechanism of enhancement of central nervous system delivery of 2'-ß-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug. Drug Metab. Dispos., 30, 191-198.
64. Herdewijn, P., Pauwels, R., Baba, M., et al. (1987) Synthesis and anti-HIV activity of various 2-and 3-substituted 2,3-dideoxyadenosines: a structure- activity analysis. J. Med. Chem., 20, 2131-2137.
65. Marquez, V. E. (1989) Design, synthesis, and antiviral activity of nucleoside and nucleotide analogs. Nucleotide Analogues Antiviral Agents, ACS Symposium Series 401, pp. 140-155.
66. Wysocki, R. J., Jr., Siddiqui, M. A., Barchi, J. J., Jr., et al. (1991) A more expedient approach to the synthesis of anti-HIV-active 2,3-dideoxy-2-fluoro-ß-D-threo-pentofuranosyl nucleosides. Synthesis, 1005-1008.
67. Siddiqui, M. A., Marquez, V. E., Driscoll, J. S. and Barchi, J. J., Jr. (1994) A diastereo-selective synthesis of (S,S)-a-fluoro-2,2-dimethyl-1,3-dioxolane-4-propanoic acid methyl ester, a key intermediate for the preparation of anti-HIV effective fluorodideoxy nucleosides. Tetrahedron Lett., 35, 3263-3266.
68. Siddiqui, M. A., Driscoll, J. S., Abushanab, E., et al. (2000) The "ß-fluorine effect" in the non-metal hydride radical deoxygenation of fluorine-containing nucleoside xanthates. Nucleosides, Nucleotides, Nucleic Acids, 19, 1-12.
69. Caille, J.-C., Miel, H., Armstrong, P. and McKervey, M. A. (2004) A new synthetic approach to 2,3-dideoxy-2-fluoro-ß-D-threo-pentofuranose, the fluorofuranose unit of the anti-HIV-active nucleoside, ß-FddA. Tetrahedron Lett., 45, 863-865.
70. Shanmuganathan, K., Koudriakova, T., Nampalli, S., et al. (1994) Enhanced brain delivery of an anti-HIV nucleoside 2-F-ara-ddI by xanthine oxidase mediated biotransformation. J. Med. Chem., 37, 821-827.
71. Jin, F., Wang, D., Confalone, P. N., et al. (2001) (2R,3S,5S)-2-Acetoxy-3-fluoro-5-(p-toluoy-loxymethyl) tetrahydrofuran: a key intermediate for the practical synthesis of 9- (2,3-dideoxy -2-fluoro-ß-D-threo-pentofuranosyl)adenine (FddA). Tetrahedron Lett., 42, 4787-4789.
72. Choudhury, A., Jin, F., Wang, D., et al. (2003) A concise synthesis of anti- viral agent F-ddA, starting from (S)-dihydro-5-(hydroxymethyl)-2(3H)-furanone. Tetrahedron Lett., 44, 247-250.
73. Takamatsu, S., Maruyama, T., Katayama, S., et al. (2001) Improved synthesis of 9-(2,3-dideoxy-2-fluoro-ß-D-threo-pentofuranosyl)adenine (FddA) using triethylamine trihydrofluo-ride. Tetrahedron Lett., 42, 2321-2324.
74. Barton, D. H. R., Jang, D. O. and Jaszberenyi, J. C. (1993) The invention of radical reactions. Part 32. Radical deoxygenations, dehalogenations, and deaminations with dialkyl phosphites and hypophosphorous acid as hydrogen sources. J. Org. Chem., 58, 6838-6842.
75. Takamatsu, S., Katayama, S., Hirose, N., et al. (2001) Radical deoxygenation and dehalogena-tion of nucleoside derivatives with hypophosphorous acid and dialkyl phosphites. Tetrahedron Lett., 42, 7605-7608.
76. Shiragami, H., Tanaka, Y., Uchida, Y., et al. (1992) A novel method for the synthesis of ddA and F-ddA via regioselective 2' -O-deacetylation of 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-ß-D-xylofuranosyl)adenine. Nucleosides Nucleotides, 11, 391-100.
77. Shiragami, H., Amino, Y., Honda, Y., et al. (1996) Synthesis of 2',3'-dideoxypurinenucleosides via the palladium catalyzed reduction of 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-ß-D-xylofuranosyl)purine derivatives. Nucleosides Nucleotides, 15, 31-15.
78. Takamatsu, S., Maruyama, T., Katayama, S., et al. (2001) Practical synthesis of 9-(2,3-dideoxy-2-fluoro-ß-D-threo-pentofuranosyl) adenine (FddA) via a purine 3'-deoxynucleoside. Tetrahedron Lett., 42, 2325-2328.
79. Takamatsu, S., Maruyama, T., Katayama, S., et al. (2001) Synthesis of 9-(2,3-dideoxy-2-fluoro-ß-D-threo-pentofuranosyl)adenine (FddA) via a purine 3' -deoxynucleoside. J. Org. Chem., 66, 7469-7477.
80. Takamatsu, S., Katayama, S., Hirose, N., et al. (2002) Convenient synthesis of fluorinated nucleosides with perfluoroalkanesulfonyl fluorides. Nucleosides, Nucleotides, Nucleic Acids, 21, 849-861.
81. Balzarini, J., Baba, M., Pauwels, R., et al. (1988) Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3' -fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus. Mol. Pharmacol., 33, 243-249.
82. Herdewijn, P., Balzarini, J., Baba, M., et al. (1988) Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. J. Med. Chem., 31, 2040-2048.
83. Schröder, I., Holmgren, B., Öberg, M. and Löfgren, B. (1998) Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro. Antivir. Res., 37, 57-66.
84. Hafkemeyer, P., Keppler-Hafkemeyer, A., al Haya, M. A., et al. (1996) Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoro- guanosine in vitro and in vivo. Antimi-crob. Agents Chemother. 40, 792-794.
85. Jacquard, A.-C., Brunelle, M.-N., Pichoud, C., et al. (2006) In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine. Antimicrob. Agents Chemother., 50, 955-961.
86. Marchand, A. Mathé, C., Imbach, J.-L. and Gosselin, G. (2000) Synthesis and antiviral evaluation of unnatural ß-L-enantiomers of 3'-fluoro- and 3'-azido-2',3'-dideoxy- guanosine derivatives. Nucleosides, Nucleotides Nucleic Acids, 19, 205-217.
87. Chun, B. K., Schinazi, R. F., Cheng, Y. C. and Chu, C. K. (2000) Synthesis of 2',3'-dideoxy-3'-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol. Carbohydr. Res., 328, 49-59.
88. Komatsu, H., Awano, H., Tanikawa, H., et al. (2001) Large-scale manufacturing of all four 2 -deoxynucleosides via novel strategies including a chemo- enzymatic process. Nucleosides, Nucleotides Nucleic Acids, 20, 1291-1293.
89. Komatsu, H. and Araki, T. (2003) Chemo-enzymatic synthesis of 2',3'-dideoxy-3'- fluoro-ß-D-guanosine via 2,3-dideoxy-3-fluoro-a-D-ribose 1-phosphate. Tetrahedron Lett., 44, 2899-2901.
90. Torii, T., Onishi, T., Izawa, K., et al. (2006) Synthesis of 6-arylthio analogs of 2',3'-dideoxy-3'-fluoroguanosine and their effect against hepatitis B virus replication. Nucleosides, Nucleo-tides Nucleic Acids, 25, 655-665.
91. Torii, T., Onishi, T., Tanji, S. and Izawa, K. (2005) Synthesis study of 3'-a-fluoro -2',3'-dide-oxyguanosine. Nucleosides, Nucleotides Nucleic Acids, 24, 1051-1054.
92. Ishii, A., Otsuka, T., Kume, K., et al. (2006) Regioselective preparation of 2-halo-2,3-dideoxy-3-fluoro-ß-D-arabinofuranosyl nucleosides and their dehalogenation products. JP Patent 2006022009.
93. Torii, T., Onishi, T., Izawa, K. and Maruyama, T. (2006) A concise synthesis of 3'-a-fluoro-2',3'-dideoxyguanosine (FddG) via 3'-a-selective fluorination of 8,2'-thioanhydronucleoside. Tetrahedron Lett., 47, 6139-6141.
94. Cushley, R. J., Codington, J. F. and Fox, J. J. (1968) Nucleosides. XLIX. Nuclear magnetic resonance studies of 2' -and 3'-halogeno nucleosides. The conformations of 2'-deoxy-2'-fluorouridine and 3'-deoxy-3'-fluoro-ß-D-arabinofuranosyluracil. Can. J. Chem., 46, 1131-1140.
95. Guschlbauer, W. and Krzysztof, J. (1980) Nucleoside conformation is determined by the electronegativity of the sugar substituent. Nucleic Acids Res., 8, 1421-1433.
96. Hakoshima, T., Omori, H., Tomita, K., et al. (1981) The crystal and molecular structure of 2' -deoxy-2'-fluoroinosine monohydrate. Nucleic Acids Res., 9, 711-729.
97. Uesugi, S., Miki, H. and Ikehara, M. (1981) Studies on nucleosides and nucleotides. LXXXVIII. Purine cyclo-nucleosides. XLIII. 13C NMR spectra of 2'-substituted 2'-deoxyadenosines. Substituent effects on the chemical shifts in the furanose ring system. Chem. Pharm. Bull., 29, 2199-2204.
98. Uesugi, S., Takatsuka, Y., Ikehara, M., et al. (1981) Synthesis and characterization of the dinucleoside monophosphates containing 2'-fluoro-2'-deoxyadenosine. Biochemistry, 20, 3056-3062.
99. Chandra, P., Demirhan, I. and De Clercq, E. (1981) A study of antitemplate inhibition of mammalian, bacterial and viral DNA polymerases by 2- and 2' -substituted derivatives of polyade-nylic acid. Cancer Lett., 12, 181-193.
100. Fukui, T., De Clerq, E., Kakiuchi, N. and Ikehara, M. (1982) Template activity of poly(2'-fluoro-2'-deoxyinosinic acid) for murine leukemia virus reverse transcriptase. Cancer Lett.,16, 129-135.
101. Aoyama, H., Sarih-Cottin, L., Tarrago-Litvak, L., et al. (1985) 2'-Fluoro-2'-deoxypolynucleotides as templates and inhibitors for RNA- and DNA-dependent DNA poly-merases. Biochim. Biophys. Acta, 824, 225-232.
102. Fukui, T., Kakiuchi, N. and Ikehara, M. (1982) Protein synthesis using poly(2'-halogeno-2'-deoxyadenylic acids) as messenger. Biochim. Biophys. Acta, 697, 174-177.
103. Aurup, H., Siebert, A., Benseler, F., et al. (1994) Translation of 2'-modified mRNA in vitro and in vivo. Nucleic Acids Res., 22, 4963-4968.
104. De Clercq, E., Stollar, B. D., Hobbs, J., et al. (1980) Interferon induction by two 2'-modified double-helical RNAs, poly(2'-nuoro-2'-deoxymosimc acid) • poly(cytidylic acid) and poly(2'-chloro-2'-deoxyinosinic acid) • poly(cytidylic acid). Eur. J. Biochem., 107, 279-288.
105. Tuttle, J. V., Tisdale, M. and Krenitsky, T. A. (1993) Purine 2'-deoxy-2'-fluororibosides as antiinfluenza virus agents. J. Med. Chem., 36, 119-125.
106. Tisdale, M., Appleyard, G., Tuttle, et al. (1993) Inhibition of influenza A and B viruses by 2'-deoxy-2'-fluororibosides. Antiviral Chem. Chemother., 4, 281-287.
107. Clark, J. L., Hollecker, L., Mason, J. C., et al. (2005) Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. J. Med. Chem., 48, 5504-5508.
108. Murakami, E., Bao, H., Ramesh, M., et al. (2007) Mechanism of activation of ß-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase. Antimicrob. Agents Chemother. 51, 503-509.
109. Mu, L., Sarafianos, S. G., Nicklaus, M. C., et al. (2000) Interactions of conformationally biased north and south 2'-fluoro-2',3'-dideoxynucleoside 5'-triphosphates with the active site of HIV-1 reverse transcriptase. Biochemistry, 39, 11205-11215.
110. Khripach, N. B., Pupeiko, N. E., Skorynin, I. Yu. and Borisov, E. V. (1991) Conformational characteristics of 3'-deoxy-3'-fluoro- and 2',3'-dideoxy-3'-fluororibonucleosides. Bioor-ganicheskaya Khimiya, 17, 1521-1525.
111. Plavec, J., Koole, L. H., Sandström, A. and Chattopadhyaya, J. (1991) Structural studies of anti-HIV 3'-a-fluorothymidine and 3'-a-azidothymidine by 500 MHz 1H-NMR spectroscopy and molecular mechanics (MM2) calculations. Tetrahedron, 47, 7363-7376.
112. Barchi, J. J., Jr, Jeong, L.-S., Siddiqui, M. A. and Marquez, V. E. (1997) Conformational analysis of the complete series of 2' and 3' monofluorinated dideoxyuridines. J. Biochem. Biophys. Methods, 34, 11-29.
113. Van Roey, P., Salerno, J. M., Chu, C. K. and Schinazi, R. F. (1989) Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 86, 3929-3933.